Department of Public Health, Erasmus MC, Rotterdam, The Netherlands.
Cambridge Oesophago-Gastric Centre, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Br J Surg. 2016 Jan;103(1):105-16. doi: 10.1002/bjs.9968. Epub 2015 Nov 26.
Outcomes for oesophagogastric cancer surgery are compared with the aim of benchmarking quality of care. Adjusting for patient characteristics is crucial to avoid biased comparisons between providers. The study objective was to develop a case-mix adjustment model for comparing 30- and 90-day mortality and anastomotic leakage rates after oesophagogastric cancer resections.
The study reviewed existing models, considered expert opinion and examined audit data in order to select predictors that were consequently used to develop a case-mix adjustment model for the National Oesophago-Gastric Cancer Audit, covering England and Wales. Models were developed on patients undergoing surgical resection between April 2011 and March 2013 using logistic regression. Model calibration and discrimination was quantified using a bootstrap procedure.
Most existing risk models for oesophagogastric resections were methodologically weak, outdated or based on detailed laboratory data that are not generally available. In 4882 patients with oesophagogastric cancer used for model development, 30- and 90-day mortality rates were 2·3 and 4·4 per cent respectively, and 6·2 per cent of patients developed an anastomotic leak. The internally validated models, based on predictors selected from the literature, showed moderate discrimination (area under the receiver operating characteristic (ROC) curve 0·646 for 30-day mortality, 0·664 for 90-day mortality and 0·587 for anastomotic leakage) and good calibration.
Based on available data, three case-mix adjustment models for postoperative outcomes in patients undergoing curative surgery for oesophagogastric cancer were developed. These models should be used for risk adjustment when assessing hospital performance in the National Health Service, and tested in other large health systems.
为了基准化医疗质量,比较了食管胃交界癌手术的结果。调整患者特征对于避免提供者之间的有偏差比较至关重要。本研究的目的是开发一种病例组合调整模型,以比较食管胃交界癌切除术后 30 天和 90 天的死亡率和吻合口漏发生率。
该研究回顾了现有模型,考虑了专家意见并检查了审计数据,以选择预测因子,随后将其用于开发国家食管胃交界癌审计的病例组合调整模型,涵盖英格兰和威尔士。使用逻辑回归在 2011 年 4 月至 2013 年 3 月期间接受手术切除的患者中开发模型。使用自举程序来量化模型校准和区分度。
大多数现有的食管胃切除术风险模型在方法学上存在缺陷,已经过时,或者基于一般不可用的详细实验室数据。在用于模型开发的 4882 例食管胃交界癌患者中,30 天和 90 天的死亡率分别为 2.3%和 4.4%,6.2%的患者发生吻合口漏。基于文献中选择的预测因子的内部验证模型显示出中等的区分度(30 天死亡率的接收者操作特征曲线下面积为 0.646,90 天死亡率为 0.664,吻合口漏为 0.587)和良好的校准。
基于现有数据,为接受根治性手术治疗的食管胃交界癌患者开发了三种术后结局的病例组合调整模型。在评估国民保健制度中医院绩效时,应使用这些模型进行风险调整,并在其他大型卫生系统中进行测试。